News & Updates
Filter by Specialty:
Hypertension in pregnancy ups risk of poor delivery, infant outcomes
Hypertensive disorders in pregnancy seem to aggravate the risk of premature delivery and intrauterine growth retardation, reports a recent study. Consequentially, the delivered infants may be more likely to sustain injuries to the cardiovascular and endocrine system and suffer from neurodevelopmental delays.
Hypertension in pregnancy ups risk of poor delivery, infant outcomes
25 Feb 2022
Post-MPI statin use prevents MACE in patients with elevated coronary artery calcium score
Use of moderate- to high-intensity statins (MHIS) after myocardial perfusion imaging (MPI) leads to significantly fewer major adverse cardiovascular events (MACE) and is an independent negative predictor for 24-months MACE among patients with normal MPI and coronary artery calcium (CAC) score >300, a Singapore study has shown.
Post-MPI statin use prevents MACE in patients with elevated coronary artery calcium score
23 Feb 2022
Hypertension in pregnancy: Labetalol extends benefits for pregnancy outcomes
Common blood pressure (BP)-lowering medications in pregnancy cut the risk of severe hypertension, but labetalol has the added advantage of reducing the risks of proteinuria or pre-eclampsia and perinatal death, according to the results of a network meta-analysis.
Hypertension in pregnancy: Labetalol extends benefits for pregnancy outcomes
22 Feb 2022
NOACs preferable over warfarin in AF patients with bioprosthetic valves
Use of nonvitamin K oral anticoagulants (NOACs) results in a reduced incidence of thromboembolic events and major bleeding relative to warfarin in patients with atrial fibrillation (AF) and bioprosthetic valves or valve repair, suggests a study.
NOACs preferable over warfarin in AF patients with bioprosthetic valves
22 Feb 2022
Elevated dietary glycaemic index, load linked to higher CVD mortality risk
Dietary patterns with higher glycaemic index (GI) and glycaemic load (GL) appear to elevate the risk of cardiovascular disease (CVD) mortality, according to a study on Chinese adults.
